Substance
ID:449233
Names and Identifiers
IUPAC name
(2S)-3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2λ5-oxazaphosphinan-2-one
IUPAC Traditional name
(2S)-3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2λ5-oxazaphosphinan-2-one
Synonyms
IfosfamideDexifosfamide
Registration numbers
CAS Number
Properties
Product Information
Application(s)
Antineoplastic
Antileukaemic
Immunosuppressant
Pharmacology Properties
Mechanism of Action
Alkylating agent in cancer therapy
Molecule Details
No Data Available
Click here to submit data
Molecular Spectra
No Data Available
Click here to submit data
References
• Schulten, H.-R., Biomed. Mass Spectrom., 1974, 1, 223, (ms)
• Pankiewicz, K. et al., J.A.C.S., 1979, 101, 7712, (config)
• Su, C.N. et al., J.A.C.S., 1982, 104, 7343, (cd)
• Martindale, The Extra Pharmacopoeia, 30th edn., Pharmaceutical Press, 1993, 483
• Wroblewski, A.E. et al., Inorg. Chem., 1980, 19, 3713, (complexes, resoln)
• Gilard, V. et al., J. Med. Chem., 1999, 42, 2542-2560, (pharmacol, metab)
• Takamizawa, A. et al., Chem. Pharm. Bull., 1977, 25, 2900, (metab)
• Ludeman, S.M. et al., J.O.C., 1979, 44, 1163, (synth)
• Misiura, K. et al., J. Med. Chem., 1983, 26, 674, (metab)
• Brade, W.P. et al., Drugs of Today (Barcelona), 1984, 20, 491, (rev)
• Kleinrok, Z. et al., Arch. Immunol. Ther. Exp., 1986, 34, 293, (pharmacol, isom)
• IARC Monog., 1981, 26, 237; Suppl. 7, 65, (rev, tox)
• Brade, W.P. et al., Cancer Treat. Rep., 1985, 12, 1, (pharmacol, tox, use, rev)
• Kupfer, A. et al., Lancet, 1990, 335, 1461, (metab)
• Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, IMH000
• Kinas, R.W. et al., Bull. Acad. Pol. Sci., Ser. Sci. Chim., 1978, 26, 39, (resoln)
• Anticancer Drug Research. Lectures and Symposia 14th Int. Cancer Congress, Budapest, (ed., Lapis, K. et al), 1986, 9, 127; 133; 139; 155; 171; 177, (rev)
• Perales, A. et al., Acta Cryst. B, 1977, 33, 1935, (cryst struct)
• Buess, M.L. et al., Org. Magn. Reson., 1984, 22, 67, (nqr)